• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A very low number of circulating basophils is predictive of a poor response to omalizumab in chronic spontaneous urticaria.

作者信息

Rijavec Matija, Košnik Mitja, Koren Ana, Kopač Peter, Šelb Julij, Vantur Romana, Kogovšek Žan, Bizjak Mojca, Bajrović Nissera, Zidarn Mihaela, Korošec Peter

机构信息

University Clinic of Respiratory and Allergic Diseases Golnik, Golnik, Slovenia.

Biotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia.

出版信息

Allergy. 2021 Apr;76(4):1254-1257. doi: 10.1111/all.14577. Epub 2020 Sep 17.

DOI:10.1111/all.14577
PMID:32876979
Abstract
摘要

相似文献

1
A very low number of circulating basophils is predictive of a poor response to omalizumab in chronic spontaneous urticaria.循环嗜碱性粒细胞数量极低预示着慢性自发性荨麻疹患者对奥马珠单抗治疗反应不佳。
Allergy. 2021 Apr;76(4):1254-1257. doi: 10.1111/all.14577. Epub 2020 Sep 17.
2
Improved FcεRI-Mediated CD203c Basophil Responsiveness Reflects Rapid Responses to Omalizumab in Chronic Spontaneous Urticaria.改善的 FcεRI 介导的 CD203c 嗜碱性粒细胞反应反映了奥马珠单抗对慢性自发性荨麻疹的快速反应。
J Allergy Clin Immunol Pract. 2021 Mar;9(3):1166-1176.e8. doi: 10.1016/j.jaip.2020.08.048. Epub 2020 Sep 6.
3
[HOW PERIPHERAL BASOPHILS IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA ARE CHANGED WITH OMALIZUMAB TREATMENT?].[慢性自发性荨麻疹患者外周嗜碱性粒细胞经奥马珠单抗治疗后有何变化？]
Arerugi. 2021;70(9):1196-1199. doi: 10.15036/arerugi.70.1196.
4
Double-blind placebo-controlled trial of the effect of omalizumab on basophils in chronic urticaria patients.奥马珠单抗对慢性荨麻疹患者嗜碱性粒细胞影响的双盲安慰剂对照试验。
Clin Exp Allergy. 2018 Feb;48(2):196-204. doi: 10.1111/cea.13066. Epub 2017 Dec 12.
5
Unique basophil microRNA signature in chronic spontaneous urticaria patients who respond to omalizumab.对奥马珠单抗有反应的慢性自发性荨麻疹患者独特的嗜碱性粒细胞微小RNA特征。
Clin Exp Allergy. 2021 Dec;51(12):1648-1652. doi: 10.1111/cea.14014. Epub 2021 Sep 20.
6
Positive basophil histamine release assay predicts insufficient response to standard-dosed omalizumab in patients with chronic spontaneous urticaria.嗜碱性粒细胞组胺释放试验阳性预示慢性自发性荨麻疹患者对标准剂量奥马珠单抗反应不足。
Clin Exp Allergy. 2023 Dec;53(12):1318-1321. doi: 10.1111/cea.14402. Epub 2023 Sep 28.
7
Response of peripheral blood basophils in subjects with chronic spontaneous urticaria during treatment with omalizumab.奥马珠单抗治疗慢性自发性荨麻疹患者外周血嗜碱性粒细胞的反应。
J Allergy Clin Immunol. 2021 Jun;147(6):2295-2304.e12. doi: 10.1016/j.jaci.2021.02.039. Epub 2021 Mar 12.
8
Basophil FcεRI Expression in Chronic Spontaneous Urticaria: A Potential Immunological Predictor of Response to Omalizumab Therapy.慢性自发性荨麻疹中嗜碱性粒细胞FcεRI的表达：对奥马珠单抗治疗反应的潜在免疫预测指标
Acta Derm Venereol. 2017 Jun 9;97(6):698-704. doi: 10.2340/00015555-2654.
9
Effects of omalizumab on basophils: Potential biomarkers in asthma and chronic spontaneous urticaria.奥马珠单抗对嗜碱性粒细胞的影响：哮喘和慢性自发性荨麻疹的潜在生物标志物。
Cell Immunol. 2020 Dec;358:104215. doi: 10.1016/j.cellimm.2020.104215. Epub 2020 Sep 12.
10
Omalizumab is effective in patients with chronic spontaneous urticaria plus multiple chronic inducible urticaria.奥马珠单抗对慢性自发性荨麻疹合并多种慢性诱导性荨麻疹患者有效。
Eur Ann Allergy Clin Immunol. 2021 Mar;53(2):91-93. doi: 10.23822/EurAnnACI.1764-1489.153. Epub 2021 Mar 1.

引用本文的文献

1
Utility of serum biomarkers in real-world practice for predicting response to omalizumab therapy in patients with chronic spontaneous urticaria.血清生物标志物在慢性自发性荨麻疹患者中预测奥马珠单抗治疗反应的真实世界实践中的效用。
J Allergy Clin Immunol Glob. 2024 Dec 12;4(1):100386. doi: 10.1016/j.jacig.2024.100386. eCollection 2025 Feb.
2
Pathophysiological Mechanisms of the Onset, Development, and Disappearance Phases of Skin Eruptions in Chronic Spontaneous Urticaria.慢性自发性荨麻疹皮肤疹发生、发展和消退阶段的病理生理机制。
Bull Math Biol. 2024 Nov 14;87(1):1. doi: 10.1007/s11538-024-01380-3.
3
Prognosis of chronic spontaneous urticaria with an inadequate response to omalizumab.
对奥马珠单抗反应不足的慢性自发性荨麻疹的预后
Int J Dermatol. 2025 Feb;64(2):349-358. doi: 10.1111/ijd.17547. Epub 2024 Nov 3.
4
Key differences between chronic inducible and spontaneous urticaria.慢性诱导性荨麻疹与自发性荨麻疹之间的关键差异。
Front Allergy. 2024 Oct 17;5:1487831. doi: 10.3389/falgy.2024.1487831. eCollection 2024.
5
Autoimmune Mast Cell Activation Test as a Diagnostic Tool in Chronic Spontaneous Urticaria.自身免疫性肥大细胞活化试验在慢性自发性荨麻疹中的诊断作用。
Int J Mol Sci. 2024 Aug 27;25(17):9281. doi: 10.3390/ijms25179281.
6
Omalizumab in Chronic Spontaneous Urticaria: A Real-World Study on Effectiveness, Safety and Predictors of Treatment Outcome.奥马珠单抗治疗慢性自发性荨麻疹：一项关于有效性、安全性及治疗结果预测因素的真实世界研究
Clin Cosmet Investig Dermatol. 2024 Aug 7;17:1799-1808. doi: 10.2147/CCID.S470160. eCollection 2024.
7
Research progress in the pathogenesis of chronic urticaria.慢性荨麻疹发病机制的研究进展
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Oct 28;48(10):1602-1610. doi: 10.11817/j.issn.1672-7347.2023.230037.
8
Basophil Characteristics as a Marker of the Pathogenesis of Chronic Spontaneous Urticaria in Relation to the Coagulation and Complement Systems.嗜碱性粒细胞特征作为慢性自发性荨麻疹发病机制的标志物与凝血及补体系统的关系。
Int J Mol Sci. 2023 Jun 19;24(12):10320. doi: 10.3390/ijms241210320.
9
Genetic Variants Leading to Urticaria and Angioedema and Associated Biomarkers.导致荨麻疹和血管性水肿的遗传变异及其相关生物标志物。
J Allergy Clin Immunol Pract. 2023 Aug;11(8):2286-2301. doi: 10.1016/j.jaip.2023.05.031. Epub 2023 May 30.
10
Comorbidities of Chronic Urticaria: A glimpse into a complex relationship.慢性荨麻疹的合并症：洞察复杂关系
Front Allergy. 2022 Nov 17;3:1008145. doi: 10.3389/falgy.2022.1008145. eCollection 2022.